Evidence map›Paper›PMID 34285943›Full record

ArticleInternational journal of particle therapy2021

Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers.

Michael T Spiotto, Susan L McGovern, G Brandon Gunn, David Grosshans, Mary Frances McAleer, Steven J Frank, Arnold C Paulino

Open access · diamondAbstract read
In one paragraph

Article in International journal of particle therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The Evolution of Radiation Therapy in Children's Oncology Group Trials, From 1998 to 2025.International journal of radiation oncology, biology, physics · 2026
    Article
  4. Article
  5. Development of a practice-based score to predict extended duration of proton beam therapy session in pediatric patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. An Experimental Model of Proton-Beam-Induced Radiation Dermatitis In Vivo.International journal of molecular sciences · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michael T SpiottoDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Susan L McGovernDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
G Brandon GunnDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
David GrosshansDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mary Frances McAleerDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Steven J FrankDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Arnold C PaulinoDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Viral Replication Pathways During Oral Tumorigenesis and Response to TherapyR01DE027445 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPIOTTO, MICHAEL T · 2018 to 2022
$1.9M
NIDCR NIH HHS R01 DE027445
6 · The paper itself

Abstract

In most childhood head and neck cancers, radiotherapy is an essential component of treatment; however, it can be associated with problematic long-term complications. Proton beam therapy is accepted as a preferred radiation modality in pediatric cancers to minimize the late radiation side effects. Given that childhood cancers are a rare and heterogeneous disease, the support for proton therapy comes from risk modeling and a limited number of cohort series. Here, we discuss the role of proton radiotherapy in pediatric head and neck cancers with a focus on reducing radiation toxicities. First, we compare the efficacy and expected toxicities in proton and photon radiotherapy for childhood cancers. Second, we review the benefit of proton radiotherapy in reducing acute and late radiation toxicities, including risks for secondary cancers, craniofacial development, vision, and cognition. Finally, we review the cost effectiveness for proton radiotherapy in pediatric head and neck cancers. This review highlights the benefits of particle radiotherapy for pediatric head and neck cancers to improve the quality of life in cancer survivors, to reduce radiation morbidities, and to maximize efficient health care use.

Indexed as

neoplasms, radiation-inducedproton therapyradiotherapyradiotherapy, intensity-modulated

Identifiers

PMID34285943
PMCPMC8270100
OpenAlexW3176605130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.